| AST | Aspartate aminotransferase |
| CAD | Coronary artery disease |
| CKD | Chronic kidney disease |
| COPD | Chronic obstructive pulmonary disease |
| CoQ10 | Coenzyme Q10 |
| CRP | C-reactive protein |
| eNOS | Endothelial nitric oxide synthase |
| EPCs | Endothelial progenitor cells |
| ESRD | End-stage renal disease |
| FMD | Flow-mediated dilation |
| GGT | Gamma-glutamyl transpeptidase |
| HF | Heart failure |
| HOMA-IR | Homeostatic model assessment of insulin resistance |
| hs-CRP | High-sensitivity C-reactive protein |
| Lp(a) | Lipoprotein (a) |
| MACE | Major adverse cardiac events |
| MitoQ | Mitochondrial-targeting antioxidant |
| MSA | Multiple system atrophy |
| NAFLD | Non-alcoholic fatty liver disease |
| NFκB | Nuclear factor kappa B |
| NMD | Nitroglycerin-mediated dilation |
| PPAR-γ | Peroxisome proliferator-activated receptor-gamma |
| RCTs | Randomized clinical trials |
| ROS | Reactive oxygen species |
| SQOR | Sulfide:quinone oxidorreductase |
| TAC | Total antioxidant capacity |
| TG | Triglyceride |